Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Gensia coagulation monitoring system enters phase I

May 3, 1996

Stealth liposomes possess prolonged stability

May 3, 1996

Cadus/Solvay yeast-based drug discovery program receives boost from EC

May 3, 1996

Drug discovery agreement reached by CombiChem and Teijin

May 3, 1996

Anaderm Research formed to develop skin and hair therapeutics

May 3, 1996

Sunrise Technologies will expand phase II LTK trials

April 26, 1996

VIMRx acquires rights to compounds based on RILON technology

April 26, 1996

SKB receives rights to OraSolve dosage technology from CIMA

April 26, 1996

Oxford Molecular, Yamanouchi to codevelop ion channel modulators

April 26, 1996

RMP-7 advances to phase I/II in Europe

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...